Mirati Therapeutics Inc. buy melinda
Start price
15.10.17
/
50%
€13.08
Target price
16.10.17
€13.08
Performance (%)
0.69%
End price
16.10.17
€13.17
Summary
This prediction ended on 16.10.17 with a price of €13.17. The BUY prediction by melinda for Mirati Therapeutics Inc. closed nearly unchanged. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by melinda for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Lunge
Phase 2 Poster werden auf der Weltkonferenz für Lungenkrebs 16 bis 18. Oktober 2017 erwartet.
Stopped prediction by melinda for Mirati Therapeutics Inc.
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€95.50
26.11.22
26.11.22
-
26.11.23
26.11.23
-45.74%
27.11.23
27.11.23
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€121.45
21.08.20
21.08.20
€130.00
04.11.21
04.11.21
19.06%
05.11.21
05.11.21
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.64
05.05.19
05.05.19
€69.45
11.06.19
11.06.19
55.44%
11.06.19
11.06.19
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.96
07.03.18
07.03.18
€29.77
09.03.18
09.03.18
6.94%
09.03.18
09.03.18
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.50
15.10.17
15.10.17
€14.50
16.10.17
16.10.17
0.69%
16.10.17
16.10.17
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.90
12.04.17
12.04.17
€4.69
26.04.17
26.04.17
7.51%
26.04.17
26.04.17
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.15
13.06.16
13.06.16
€10.37
13.12.16
13.12.16
-28.12%
13.12.16
13.12.16